Industry Leading Press Release Distribution Service
Industry Leading Press Release Distribution Service
Reach Thousands of the Right Investors at the Right Time
Reach Thousands of the
Right Investors
at the
Right Time
- Get published in newsletters and websites read by investors.
- Target active investors.
- Get into the most important news databases and news wires across the country.
- Reach journalists and media influencers.
- Attain long-term visibility in search engines & SEO benefits.
- Have your releases turned into articles that live on past the release date.
- Cost-effective direct marketing that works
… And many more
Features Press Releases
Immix Biopharma Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for NXC-201, sterically-optimized CAR-T for relapsed/refractory AL Amyloi
Immix Biopharma, Inc. (Nasdaq: IMMX) (“ImmixBio”, “Company”, “We” or “Us”, “IMMX”), a clinical-stage biopharmaceutical company developing cell therapies for AL amyloidosis and select immune-mediated diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted RMAT designation to sterically-optimized CAR-T NXC-201 for the treatment of relapsed/refractory AL amyloidosis.
Office Properties Income Trust Announces Private Exchange Offers Relating to Existing 2026, 2027 and 2031 Senior Unsecured Notes
Office Properties Income Trust (Nasdaq: OPI) (“OPI”) today announced that it is offering noteholders the option to exchange their outstanding senior unsecured notes due 2026, 2027 and 2031 for new 8.000% Senior Priority Guaranteed Unsecured Notes due 2030 and related guarantees pursuant to the terms and conditions set forth in an
Wearable Devices Unveils Future AI-Powered Gesture Personalization Technology, Paving the Way for Next-Gen User Interactions
Wearable Devices Ltd. (the “Company” or “Wearable Devices”) (Nasdaq: WLDS, WLDSW), an award-winning pioneer in artificial intelligence (“AI”)-based wearable gesture control technology, is developing cutting-edge methods for gesture personalization that will transform user interactions in the near future. By harnessing biopotential signals from the human wrist, Wearable Devices is working
Schneider Electric Enhances Energy Management Controls and Capabilities with SpaceLogic™ Touchscreen Room Controller
Schneider Electric, the leader in the digital transformation of energy management and automation, announces the launch of the SpaceLogic™ Touchscreen Room Controller, an all-in-one device that leverages modern technology and seamlessly merges an innovative user interface with advanced functionality, setting a new standard for energy management and room control in
Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney
Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a key component of the immunosuppression therapy regimen in a patient who recently received a transplanted kidney from a genetically modified pig. The procedure was performed on January 25, 2025, by surgeons
BofA Receives Top Rankings in Digital, Corporate Banking and Cash Management from Crisil Coalition Greenwich
Bank of America’s commitment to digital innovation that enhances client experiences has been recognized by Crisil Coalition Greenwich in its 2024 Digital Transformation Benchmarking Study in which the bank received numerous No. 1 rankings. CashPro is the company’s digital banking platform accessed by more than 40,000 corporate and commercial clients
Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer’s Disease Following Monthly Dosing with
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance regulatory T cell (Treg) function, announced encouraging blood biomarker data from an investigator-initiated, 21-week, double-blind, placebo-controlled, exploratory Phase 2 study of LD IL-2 in patients with Alzheimer’s disease (AD). Statistically significant reduced levels
California American Water Completes Acquisition of West San Martin Water Works
California American Water, a wholly owned subsidiary of American Water, announced today that it has completed its acquisition of the West San Martin Water Works (West San Martin) system assets for $1.6 million. The acquisition adds approximately 325 new water connections to the company’s current customer base, which already includes
Introducing Byte by Yum!™, an AI-Driven Restaurant Technology Platform Powering Customer and Team Member Experiences Worldwide
Yum! Brands, Inc. (NYSE: YUM) announced today the introduction of Byte by Yum!, a comprehensive collection of proprietary Software as a Service (SaaS) AI-driven products that will enable KFC, Taco Bell, Pizza Hut and Habit Burger & Grill restaurants across the world to delight customers, streamline operations and empower teams.
Millrose Properties Set to Join S&P SmallCap 600
Millrose Properties Inc. (NYSE: MRP) will replace Ironwood Pharmaceuticals Inc. (NASD: IRWD) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, February 10. S&P 500 constituent Lennar Corp (NYSE: LEN) is spinning off Millrose Properties in a transaction expected to be completed on Friday, February 7. Following
